ConferenceJournal of Clinical Oncology · June 1, 2026
2016Background:
Bevacizumab therapy (Bev) for recurrent glioblastoma (rGBM) has not d ...
Full textCite
ConferenceNeuro-Oncology · September 8, 2023
AbstractBACKGROUNDThe Response Assessment in Neuro-Oncology (RANO) criteria for high-grade gliomas (RANO-HGG) and low-grade gli ...
Full textCite
ConferenceJournal of Clinical Oncology · June 1, 2023
2017Background: Response Assessment in Neuro-Oncology (RANO) criteria for high-grade and low-grade glioma (HGG and LGG) were developed to improve reliability of response assessment in glioma trials. Several limit ...
Full textCite
ConferenceMedical Physics · January 1, 2008
Purpose: To determine the optimal flip angle combination (oFAc) that generates voxel‐based T10 values, the median T10 for primary and nodes [formula omitted], and its implications on vascular permeability (PERM) and extracellular volu ...
Full textCite
ConferenceMedical Physics · January 1, 2007
Purpose: To evaluate the use of DCE‐MRI to measure changes in tumor physiology in LAHN cancer patients receiving TT and cisplatin based concurrent chemoradiation (ChemoRT). Material and Methods: Eligible patients with LAHN were enrolled on an IRB approved ...
Full textCite